ENDRA Life Sciences (NDRA) FCF Payout Ratio (2019 - 2021)

ENDRA Life Sciences has disclosed FCF Payout Ratio across 3 years of filings, most recently posting 0.01 for Q1 2021.

• In Q1 2021, FCF Payout Ratio fell 168.71% year-over-year to 0.01; the TTM figure through Dec 2021 stood at 0.0 (up 90.32% YoY), while the FY2021 annual figure was 0.01, up 70.34% from the prior year.
• FCF Payout Ratio grew to 0.01 in Q1 2021, from 0.16 in the prior quarter.
• Over the last five years, FCF Payout Ratio for NDRA reached as high as 0.04 in Q3 2020 and fell as low as 2.17 in Q4 2019.
• The 3-year median for FCF Payout Ratio is 0.01 (2021), against an average of 0.46.
• Annual changes were most pronounced in 2020 — FCF Payout Ratio soared 92.5% — and 2021, when it tumbled 168.71%.
• A 3-year view of FCF Payout Ratio shows it stood at 2.17 in 2019, then soared by 92.5% to 0.16 in 2020, then surged by 95.38% to 0.01 in 2021.
• According to Business Quant data, FCF Payout Ratio over the past three periods registered 0.01, 0.16, and 0.04 for Q1 2021, Q4 2020, and Q3 2020 respectively.